{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:57Z","timestamp":1791461457548,"version":"4.3.4"},"reference-count":187,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Neurocognitive disorders associated with human immunodeficiency virus (HIV) infected\nindividuals increase the risk of mortality and morbidity that remain a prevalent clinical complication\neven in the antiretroviral therapy era. It is estimated that a considerable number of people in the HIV\ncommunity are developing neurological complications at their early stages of infection. The daily lives\nof people with chronic HIV infections are greatly affected by cognitive declines such as loss of attention,\nlearning, and executive functions, and other adverse conditions like neuronal injury and dementia.\nIt has been found that the entry of HIV into the brain and subsequently crossing the blood-brain\nbarrier (BBB) causes brain cell damage, which is the prerequisite for the development of neurocognitive\ndisorders. Besides the HIV replication in the central nervous system and the adverse effects of antiretroviral\ntherapy on the BBB, a range of opportunistic infections, including viral, bacterial, and parasitic\nagents, augment the neurological complications in people living with HIV (PLHIV). Given the\nimmuno-compromised state of PLHIV, these co-infections can present a wide range of clinical syndromes\nwith atypical manifestations that pose challenges in diagnosis and clinical management, representing\na substantial burden for the public health system. Therefore, the present review narrates the\nneurological complications triggered by HIV and their diagnosis and treatment options. Moreover, coinfections\nthat are known to cause neurological disorders in HIV infected individuals are highlighted.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527322666230330083708","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T04:03:36Z","timestamp":1680494616000},"page":"284-305","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their\nDiagnosis and Therapeutic Insights"],"prefix":"10.2174","volume":"23","author":[{"given":"Sivaraman","family":"Balaji","sequence":"first","affiliation":[{"name":"Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research-Headquarters, Ansari\nNagar, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Department of Medical Elementology and Toxicology, School of Chemical and Life\nSciences, Jamia Hamdard, New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research-Headquarters, Ansari\nNagar, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/tbed.13621","volume":"67","author":"Kabapy A.F.","year":"2020","unstructured":"Kabapy A.F.; Shatat H.Z.; Abd El-Wahab E.W.; Attributes of HIV infection over decades (1982\u20132018): A systematic review and meta\u2010analysis. Transbound Emerg Dis 2020,67(6),2372-2388","journal-title":"Transbound Emerg Dis"},{"key":"ref=2","year":"2019","unstructured":"UNAIDS Available from:  2019"},{"key":"ref=3","unstructured":"HIV\/AIDS2021. World Health Organization (WHO)Available from:"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/sti.2006.023630","volume":"83","author":"Kalichman S.C.","year":"2007","unstructured":"Kalichman S.C.; Ntseane D.; Nthomang K.; Segwabe M.; Phorano O.; Simbayi L.C.; Recent multiple sexual partners and HIV transmission risks among people living with HIV\/AIDS in Botswana. Sex Transm Infect 2007,83(5),371-375","journal-title":"Sex Transm Infect"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1071\/SH14101","volume":"12","author":"Clatts M.C.","year":"2015","unstructured":"Clatts M.C.; Goldsamt L.A.; Giang L.M.; Yu G.; Sexual practices, partner concurrency and high rates of sexually transmissible infections among male sex workers in three cities in Vietnam. Sex Health 2015,12(1),39-47","journal-title":"Sex Health"},{"key":"ref=6","first-page":"331","volume":"182006 2","author":"Bertozzi S.","unstructured":"Bertozzi S.; Padian N.S.; Wegbreit J.; DeMaria L.M.; Feldman B.; Gayle H.; Gold J.; Grant R.; Isbell M.T.; HIV\/AIDS prevention and\ttreatment. Disease control priorities in developing countries. The\tInternational Bank for Reconstruction and Development \/ The\tWorld Bank; 2006. Chapter ,182006 2(2),331-69 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK11782"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3390\/ijerph17124548","volume":"17","author":"Chenneville T.","year":"2020","unstructured":"Chenneville T.; Gabbidon K.; Hanson P.; Holyfield C.; The Impact of COVID-19 on HIV treatment and research: A call to action. Int J Environ Res Public Health 2020,17(12),4548","journal-title":"Int J Environ Res Public Health"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"G\u00fcnthard H.F.","year":"2016","unstructured":"G\u00fcnthard H.F.; Saag M.S.; Benson C.A.; Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA 2016,316(2),191-210","journal-title":"JAMA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2105\/AJPH.2009.184796","volume":"100","author":"Mayer K.H.","year":"2010","unstructured":"Mayer K.H.; Venkatesh K.K.; Antiretroviral therapy as HIV prevention: Status and prospects. Am J Public Health 2010,100(10),1867-1876","journal-title":"Am J Public Health"},{"key":"ref=10","author":"Abuse S.","year":"2016","unstructured":"Abuse S.;  Office of the Surgeon General (US. Early intervention,\ttreatment, and management of substance use disorders. In: Facing\tAddiction in America: The Surgeon General's Report on Alcohol,\tDrugs, and Health. US Department of Health and Human Services 2016"},{"key":"ref=11","first-page":"41","volume":"20","author":"Spudich S.S.","year":"2012","unstructured":"Spudich S.S.; Ances B.M.; Neurologic complications of HIV infection. Top Antivir Med 2012,20(2),41-47","journal-title":"Top Antivir Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"Saylor D.","year":"2016","unstructured":"Saylor D.; Dickens A.M.; Sacktor N.; HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nat Rev Neurol 2016,12(4),234-248","journal-title":"Nat Rev Neurol"},{"key":"ref=13","first-page":"54","volume":"17","author":"Elbirt D.","year":"2015","unstructured":"Elbirt D.; Mahlab-Guri K.; Bezalel-Rosenberg S.; Gill H.; Attali M.; Asher I.; HIV-associated neurocognitive disorders (HAND). Isr Med Assoc J 2015,17(1),54-59","journal-title":"Isr Med Assoc J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/cis975","volume":"56","author":"Antinori A.","year":"2013","unstructured":"Antinori A.; Arendt G.; Grant I.; Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: A consensus report of the mind exchange program. Clin Infect Dis 2013,56(7),1004-1017","journal-title":"Clin Infect Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","volume":"13","author":"Clifford D.B.","year":"2013","unstructured":"Clifford D.B.; Ances B.M.; HIV-associated neurocognitive disorder. Lancet Infect Dis 2013,13(11),976-986","journal-title":"Lancet Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3390\/ijms19113594","volume":"19","author":"Olivier I.","year":"2018","unstructured":"Olivier I.; Cacabelos R.; Naidoo V.; Risk factors and pathogenesis of HIV-associated neurocognitive disorder: The role of host genetics. Int J Mol Sci 2018,19(11),3594","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"Wallet C.","year":"2019","unstructured":"Wallet C.; De Rovere M.; Van Assche J.; Microglial cells: The main HIV-1 reservoir in the brain. Front Cell Infect Microbiol 2019,9,362","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1212\/01.CON.0000423849.24900.ec","volume":"18","author":"Kranick S.M.","year":"2012","unstructured":"Kranick S.M.; Nath A.; Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum 2012,18(6),1319-1337","journal-title":"Continuum"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","volume":"264","author":"Eggers C.","year":"2017","unstructured":"Eggers C.; Arendt G.; Hahn K.; HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol 2017,264(8),1715-1727","journal-title":"J Neurol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"Nightingale S.","year":"2014","unstructured":"Nightingale S.; Winston A.; Letendre S.; Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 2014,13(11),1139-1151","journal-title":"Lancet Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fnagi.2019.00187","volume":"11","author":"Bandera A.","year":"2019","unstructured":"Bandera A.; Taramasso L.; Bozzi G.; HIV-associated neurocognitive impairment in the modern ART era: Are we close to discovering reliable biomarkers in the setting of virological suppression? Front Aging Neurosci 2019,11,187","journal-title":"Front Aging Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"Heaton R.K.","year":"2011","unstructured":"Heaton R.K.; Franklin D.R.; Ellis R.J.; HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011,17(1),3-16","journal-title":"J Neurovirol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000445852","volume":"43","year":"2016","unstructured":"German Advisory Committee Blood (Arbeitskreis Blut), Subgroup \u2018Assessment of Pathogens Transmissible by Blood\u2019. Human Immunodeficiency Virus (HIV). Transfus Med Hemother 2016,43(3),203-222","journal-title":"Transfus Med Hemother"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"481314","DOI":"10.1155\/2013\/481314.","author":"Santoro M.M.","year":"2013","unstructured":"Santoro M.M.; Perno C.F.;  HIV-1 genetic variability and clinical\timplications. International Scholarly Research Notices. 2013,481314"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fpubh.2017.00032","volume":"5","author":"Zulfiqar HF","year":"2017","unstructured":"Zulfiqar HF; Javed A; Sumbal ; HIV diagnosis and treatment through advanced technologies. Front Public Health 2017,5,32","journal-title":"Front Public Health"},{"key":"ref=26","unstructured":"HIV and AIDS Neuroligical complications.  NINDS.(Assessed on: 27 July 2021)."},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","volume":"8","author":"Vidya Vijayan K.K.","year":"2017","unstructured":"Vidya Vijayan K.K.; Karthigeyan K.P.; Tripathi S.P.; Hanna L.E.; Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. Front Immunol 2017,8,580","journal-title":"Front Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrmicro2747","volume":"10","author":"Engelman A.","year":"2012","unstructured":"Engelman A.; Cherepanov P.; The structural biology of HIV-1: Mechanistic and therapeutic insights. Nat Rev Microbiol 2012,10(4),279-290","journal-title":"Nat Rev Microbiol"},{"key":"ref=29","author":"Coffin J.M.","year":"1997","unstructured":"Coffin J.M.; Hughes S.H.; Varmus H.E.;  The Place of Retroviruses in Biology 1997","journal-title":"The Place of Retroviruses in Biology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"a006882","DOI":"10.1101\/cshperspect.a006882","volume":"2","author":"Hu W.S.","year":"2012","unstructured":"Hu W.S.; Hughes S.H.; HIV-1 reverse transcription. Cold Spring Harb Perspect Med 2012,2(10),a006882","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1462-5822.2012.01812.x","volume":"14","author":"Klasse P.J.","year":"2012","unstructured":"Klasse P.J.; The molecular basis of HIV entry. Cell Microbiol 2012,14(8),1183-1192","journal-title":"Cell Microbiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"a006965","DOI":"10.1101\/cshperspect.a006965","volume":"2","author":"Shaw G.M.","year":"2012","unstructured":"Shaw G.M.; Hunter E.; HIV transmission. Cold Spring Harb Perspect Med 2012,2(11),a006965","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.20121517","volume":"209","author":"Sant A.J.","year":"2012","unstructured":"Sant A.J.; McMichael A.; Revealing the role of CD4+ T cells in viral immunity. J Exp Med 2012,209(8),1391-1395","journal-title":"J Exp Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"a007054","DOI":"10.1101\/cshperspect.a007054","volume":"2","author":"Walker B.","year":"2012","unstructured":"Walker B.; McMichael A.; The T-cell response to HIV. Cold Spring Harb Perspect Med 2012,2(11),a007054","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","volume":"2","author":"Wilen C.B.","year":"2012","unstructured":"Wilen C.B.; Tilton J.C.; Doms R.W.; HIV: cell binding and entry. Cold Spring Harb Perspect Med 2012,2(8),a006866","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ni1566","volume":"9","author":"Arthos J.","year":"2008","unstructured":"Arthos J.; Cicala C.; Martinelli E.; HIV-1 envelope protein binds to and signals through integrin \u03b14\u03b27, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008,9(3),301-309","journal-title":"Nat Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","volume":"100","author":"Geijtenbeek T.B.H.","year":"2000","unstructured":"Geijtenbeek T.B.H.; Kwon D.S.; Torensma R.; DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000,100(5),587-597","journal-title":"Cell"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/08892220151126625","volume":"17","author":"Robey F.A.","year":"2001","unstructured":"Robey F.A.; Robert-Guroff M.; A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells. AIDS Res Hum Retroviruses 2001,17(6),533-541","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmicb.2016.00110","volume":"7","author":"Yokoyama M.","year":"2016","unstructured":"Yokoyama M.; Nomaguchi M.; Doi N.; Kanda T.; Adachi A.; Sato H.; In silico analysis of HIV-1 Env-gp120 reveals structural bases for viral adaptation in growth-restrictive cells. Front Microbiol 2016,7,110","journal-title":"Front Microbiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1128\/JVI.75.14.6537-6546.2001","volume":"75","author":"Julias J.G.","year":"2001","unstructured":"Julias J.G.; Ferris A.L.; Boyer P.L.; Hughes S.H.; Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J Virol 2001,75(14),6537-6546","journal-title":"J Virol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"12598","DOI":"10.1074\/jbc.M700043200","volume":"282","author":"Purohit V.","year":"2007","unstructured":"Purohit V.; Roques B.P.; Kim B.; Bambara R.A.; Mechanisms that prevent template inactivation by HIV-1 reverse transcriptase RNase H cleavages. J Biol Chem 2007,282(17),12598-12609","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"a006890","DOI":"10.1101\/cshperspect.a006890","volume":"2","author":"Craigie R.","year":"2012","unstructured":"Craigie R.; Bushman F.D.; HIV DNA integration. Cold Spring Harb Perspect Med 2012,2(7),a006890","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1128\/jvi.69.11.7122-7131.1995","volume":"69","author":"Duensing T.D.","year":"1995","unstructured":"Duensing T.D.; Fang H.; Dorward D.W.; Pincus S.H.; Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1. J Virol 1995,69(11),7122-7131","journal-title":"J Virol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-6405-2-7","volume":"2","author":"Siegert S.","year":"2005","unstructured":"Siegert S.; Thaler S.; Wagner R.; Schnierle B.S.; Assessment of HIV-1 entry inhibitors by MLV\/HIV-1 pseudotyped vectors. AIDS Res Ther 2005,2(1),7","journal-title":"AIDS Res Ther"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/s41467-017-01693-z","volume":"8","author":"Puray-Chavez M.","year":"2017","unstructured":"Puray-Chavez M.; Tedbury P.R.; Huber A.D.; Multiplex single-cell visualization of nucleic acids and protein during HIV infection. Nat Commun 2017,8(1),1882","journal-title":"Nat Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1178633717752687","author":"Ene L.","year":"2018","unstructured":"Ene L.; Human immunodeficiency virus in the brain-Culprit or facilitator? Infect Dis 2018,11","journal-title":"Infect Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","volume":"21","author":"Joseph S.B.","year":"2015","unstructured":"Joseph S.B.; Arrildt K.T.; Sturdevant C.B.; Swanstrom R.; HIV-1 target cells in the CNS. J Neurovirol 2015,21(3),276-289","journal-title":"J Neurovirol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1570162X12666140526114526","volume":"12","author":"Williams D.","year":"2014","unstructured":"Williams D.; Veenstra M.; Gaskill P.; Morgello S.; Calderon T.; Berman J.; Monocytes mediate HIV neuropathogenesis: Mechanisms that contribute to HIV associated neurocognitive disorders. Curr HIV Res 2014,12(2),85-96","journal-title":"Curr HIV Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.virusres.2005.04.009","volume":"111","author":"Kramer-H\u00e4mmerle S.","year":"2005","unstructured":"Kramer-H\u00e4mmerle S.; Rothenaigner I.; Wolff H.; Bell J.E.; Brack-Werner R.; Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005,111(2),194-213","journal-title":"Virus Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"Daneman R.","year":"2015","unstructured":"Daneman R.; Prat A.; The blood-brain barrier. Cold Spring Harb Perspect Biol 2015,7(1),a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","volume":"43","author":"Osborne O.","year":"2020","unstructured":"Osborne O.; Peyravian N.; Nair M.; Daunert S.; Toborek M.; The paradox of HIV blood\u2013brain barrier penetrance and antiretroviral drug delivery deficiencies. Trends Neurosci 2020,43(9),695-708","journal-title":"Trends Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1128\/JVI.77.7.4449-4456.2003","volume":"77","author":"Cilliers T.","year":"2003","unstructured":"Cilliers T.; Nhlapo J.; Coetzer M.; The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 2003,77(7),4449-4456","journal-title":"J Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e1004146","DOI":"10.1371\/journal.ppat.1004146","volume":"10","author":"Izquierdo-Useros N.","year":"2014","unstructured":"Izquierdo-Useros N.; Lorizate M.; McLaren P.J.; Telenti A.; Kr\u00e4usslich H.G.; Martinez-Picado J.; HIV-1 capture and transmission by dendritic cells: The role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog 2014,10(7),e1004146","journal-title":"PLoS Pathog"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2015.00212","volume":"9","author":"Atluri V.S.R.","year":"2015","unstructured":"Atluri V.S.R.; Hidalgo M.; Samikkannu T.; Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 2015,9,212","journal-title":"Front Cell Neurosci"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"482575","DOI":"10.1100\/2012\/482575","volume":"2012","author":"Louboutin J.P.","year":"2012","unstructured":"Louboutin J.P.; Strayer D.S.; Blood-brain barrier abnormalities caused by HIV-1 gp120: Mechanistic and therapeutic implications. Scientific World J 2012,2012,482575","journal-title":"Scientific World J"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12883-021-02527-8","volume":"21","author":"Anesten B.","year":"2021","unstructured":"Anesten B.; Zetterberg H.; Nilsson S.; Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection. BMC Neurol 2021,21(1),494","journal-title":"BMC Neurol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/infdis\/jix013","volume":"215","author":"Rahimy E.","year":"2017","unstructured":"Rahimy E.; Li F.Y.; Hagberg L.; Blood-brain barrier disruption is initiated during primary HIV infection and not rapidly altered by antiretroviral therapy. J Infect Dis 2017,215(7),1132-1140","journal-title":"J Infect Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jnr.10762","volume":"74","author":"Andr\u00e1s I.E.","year":"2003","unstructured":"Andr\u00e1s I.E.; Pu H.; Deli M.A.; Nath A.; Hennig B.; Toborek M.; HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003,74(2),255-265","journal-title":"J Neurosci Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13550280902769764","volume":"15","author":"Ivey N.S.","year":"2009","unstructured":"Ivey N.S.; MacLean A.G.; Lackner A.A.; Acquired immunodeficiency syndrome and the blood-brain barrier. J Neurovirol 2009,15(2),111-122","journal-title":"J Neurovirol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/infdis\/jir387","volume":"204","author":"Spudich S.","year":"2011","unstructured":"Spudich S.; Gisslen M.; Hagberg L.; Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis 2011,204(5),753-760","journal-title":"J Infect Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e0250987","DOI":"10.1371\/journal.pone.0250987","volume":"16","author":"Gisslen M.","year":"2021","unstructured":"Gisslen M.; Keating S.M.; Spudich S.; Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression. PLoS One 2021,16(5),e0250987","journal-title":"PLoS One"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3389\/fmicb.2019.02933","volume":"10","author":"Pahar B.","year":"2019","unstructured":"Pahar B.; Kuebler D.; Rasmussen T.; Quantification of viral RNA and DNA positive cells in tissues from simian immunodeficiency virus\/simian human immunodeficiency virus infected controller and progressor rhesus macaques. Front Microbiol 2019,10,2933","journal-title":"Front Microbiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e01308","DOI":"10.1128\/JVI.01308-19","volume":"94","author":"Long S.","year":"2019","unstructured":"Long S.; Fennessey C.M.; Newman L.; Evaluating the intactness of persistent viral genomes in simian immunodeficiency virus-infected rhesus macaques after initiating antiretroviral therapy within one year of infection. J Virol 2019,94(1),e01308-e01319","journal-title":"J Virol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/HIV.S36674","volume":"5","author":"Robinson-Papp J.","year":"2013","unstructured":"Robinson-Papp J.; Sch\u00fctz S.G.; HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) 2013,5,243-251","journal-title":"HIV AIDS (Auckl)"},{"key":"ref=65","author":"Daliparty V.M.","year":"2021","unstructured":"Daliparty V.M.; Balasubramanya R.;  HIV Encephalitis 2021","journal-title":"HIV Encephalitis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1468-1331.1996.tb00422.x","volume":"3","author":"S\u00e1nchez-Portocarrero J.","year":"1996","unstructured":"S\u00e1nchez-Portocarrero J.; Jim\u00e9nez-Escrig A.; P\u00e9rez-Cecilia E.; AIDS dementia complex: Incidence, clinical profile and impact of zidovudine treatment. Eur J Neurol 1996,3(3),191-197","journal-title":"Eur J Neurol"},{"key":"ref=67","author":"Eggleton J.S.","year":"2022","unstructured":"Eggleton J.S.; Nagalli S.;  Highly Active Antiretroviral Therapy (HAART) 2022","journal-title":"Highly Active Antiretroviral Therapy (HAART)"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-014-0255-3","volume":"12","author":"Zayyad Z.","year":"2015","unstructured":"Zayyad Z.; Spudich S.; Neuropathogenesis of HIV: From initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV\/AIDS Rep 2015,12(1),16-24","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s13365-022-01081-4","volume":"28","author":"Ellis R.J.","year":"2022","unstructured":"Ellis R.J.; Chenna A.; Petropoulos C.J.; Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment. J Neurovirol 2022,28(3),438-445","journal-title":"J Neurovirol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.12688\/f1000research.20634.1","volume":"9","author":"Kumar R.","year":"2020","unstructured":"Kumar R.; Understanding and managing acute encephalitis. F1000 Res 2020,9,60","journal-title":"F1000 Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1148\/rg.2019190020","volume":"39","author":"Carmo R.L.","year":"2019","unstructured":"Carmo R.L.; Alves Sim\u00e3o A.K.; Amaral L.L.; Neuroimaging of emergent and reemergent infections. Radiographics 2019,39(6),1649-1671","journal-title":"Radiographics"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"Grant I.","year":"2014","unstructured":"Grant I.; Franklin D.R.; Deutsch R.; Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 2014,82(23),2055-2062","journal-title":"Neurology"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QAI.0000000000001091","volume":"73","author":"Wendelken LA","year":"2016","unstructured":"Wendelken LA; Jahanshad N; Rosen HJ;  ApoE \u03b54 is associated\twith cognition, brain integrity and atrophy in HIV over age 60. J Acquir Immune Def Syndr (1999) 2016,73(4),426","journal-title":"J Acquir Immune Def Syndr (1999)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ajmg.b.32071","volume":"159B","author":"Levine A.J.","year":"2012","unstructured":"Levine A.J.; Service S.; Miller E.N.; Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. Am J Med Genet B Neuropsychiatr Genet 2012,159B(6),669-683","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"628296","DOI":"10.3389\/fneur.2021.628296","volume":"12","author":"Lucas S.B.","year":"2021","unstructured":"Lucas S.B.; Wong K.T.; Nightingale S.; Miller R.F.; HIV-associated CD8 encephalitis: A UK case series and review of histopathologically confirmed cases. Front Neurol 2021,12,628296","journal-title":"Front Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1258\/td.2008.080213","volume":"39","author":"Beadles W.I.","year":"2009","unstructured":"Beadles W.I.; Jahn A.; Weigel R.; Clutterbuck D.; Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi. Trop Doct 2009,39(2),78-80","journal-title":"Trop Doct"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpainsymman.2010.07.006","volume":"41","author":"Wadley A.L.","year":"2011","unstructured":"Wadley A.L.; Cherry C.L.; Price P.; Kamerman P.R.; HIV neuropathyrisk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage 2011,41(4),700-706","journal-title":"J Pain Symptom Manage"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12019-001-0020-6","volume":"27","author":"Geraci A.P.","year":"2001","unstructured":"Geraci A.P.; Simpson D.M.; Neurological manifestations of HIV-1 infection in the HAART era. Compr Ther 2001,27(3),232-241","journal-title":"Compr Ther"},{"key":"ref=79","first-page":"153","volume":"9","author":"Simpson D.M.","year":"1995","unstructured":"Simpson D.M.; Tagliati M.; Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995,9(2),153-161","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00431-014-2303-9","volume":"173","author":"Peters R.P.H.","year":"2014","unstructured":"Peters R.P.H.; Van Ramshorst M.S.; Struthers H.E.; McIntyre J.A.; Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa. Eur J Pediatr 2014,173(9),1245-1248","journal-title":"Eur J Pediatr"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0883073811405203","volume":"26","author":"Govender R.","year":"2011","unstructured":"Govender R.; Eley B.; Walker K.; Petersen R.; Wilmshurst J.M.; Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol 2011,26(11),1355-1364","journal-title":"J Child Neurol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","volume":"53","author":"Cornblath D.R.","year":"1999","unstructured":"Cornblath D.R.; Chaudhry V.; Carter K.; Total neuropathy score: Validation and reliability study. Neurology 1999,53(8),1660-1664","journal-title":"Neurology"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11908-004-0014-5","volume":"6","author":"Verma S.","year":"2004","unstructured":"Verma S.; Estanislao L.; Mintz L.; Simpson D.; Controlling neuropathic pain in HIV. Curr Infect Dis Rep 2004,6(3),237-242","journal-title":"Curr Infect Dis Rep"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1529-8027.2012.00373.x","volume":"17","author":"Kamerman P.R.","year":"2012","unstructured":"Kamerman P.R.; Moss P.J.; Weber J.; Wallace V.C.J.; Rice A.S.C.; Huang W.; Pathogenesis of HIV-associated sensory neuropathy: Evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 2012,17(1),19-31","journal-title":"J Peripher Nerv Syst"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/ilar\/ilt047","volume":"54","author":"Mangus L.M.","year":"2014","unstructured":"Mangus L.M.; Dorsey J.L.; Laast V.A.; Unraveling the pathogenesis of HIV peripheral neuropathy: Insights from a simian immunodeficiency virus macaque model. ILAR J 2014,54(3),296-303","journal-title":"ILAR J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/HIV.S36674","volume":"5","author":"Sch\u00fctz S.G.","year":"2013","unstructured":"Sch\u00fctz S.G.; Robinson-Papp J.; HIV-related neuropathy: Current perspectives. Res Palliat Care 2013,5,243-251","journal-title":"Res Palliat Care"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5455\/IJMRCR.glial-cell-hiv-sn.","volume":"2","author":"Widyadharma I.","year":"2018","unstructured":"Widyadharma I.; Barus J.; Dewi P.; Glial cells involvement in\tpathogenesis of Human Immunodeficiency Virus-Associated Sensory\tNeuropathy (HIV-SN) Int J Med Rev Case Rep 2018,2(3),49-52","journal-title":"Int J Med Rev Case Rep"},{"key":"ref=88","volume":"Vol. 145","author":"Adam J.","year":"2019","unstructured":"Adam J.; Ellis R.J.;  HIV in the cART era and the mitochondrial:immune interface in the CNS Mitochondrial Dysfunction inNeurodegeneration and Peripheral Neuropathies 2019,Vol. 145","journal-title":"HIV in the cART era and the mitochondrial:immune interface in the CNS Mitochondrial Dysfunction inNeurodegeneration and Peripheral Neuropathies"},{"key":"ref=89","first-page":"145","author":"Roda R.H.","year":"2019","unstructured":"Roda R.H.; Hoke A.;  Mitochondrial dysfunction in HIVinducedperipheral neuropathy Mitochondrial Dysfunction inNeurodegeneration and Peripheral Neuropathies 2019,145","journal-title":"Mitochondrial dysfunction in HIVinducedperipheral neuropathy Mitochondrial Dysfunction inNeurodegeneration and Peripheral Neuropathies"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJM199005103221902","volume":"322","author":"Cooley T.P.","year":"1990","unstructured":"Cooley T.P.; Kunches L.M.; Saunders C.A.; Once-daily administration of 2\u20323\u2032-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med 1990,322(19),1340-1345","journal-title":"N Engl J Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1212\/01.wnl.0000316390.17248.65","volume":"71","author":"Wright E.","year":"2008","unstructured":"Wright E.; Brew B.; Arayawichanont A.; Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 2008,71(1),50-56","journal-title":"Neurology"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nm0595-417","volume":"1","author":"Lewis W.","year":"1995","unstructured":"Lewis W.; Dalakas M.C.; Mitochondrial toxicity of antiviral drugs. Nat Med 1995,1(5),417-422","journal-title":"Nat Med"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40001-021-00483-0","volume":"26","author":"Mongezi T.","year":"2021","unstructured":"Mongezi T.; Sibi J.; Jerry G.; Lourdes de F\u00e1tima I.V.; Tozama D.; Humberto F.S.; Atypical HIV-vacuolar myelopathy: A case report. Eur J Med Res 2021,26(1),13","journal-title":"Eur J Med Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3842425","volume":"2019","author":"Wuliji N.","year":"2019","unstructured":"Wuliji N.; Mandell M.J.; Lunt J.M.; Merando A.; HIV-associated vacuolar myelopathy and HIV-associated dementia as the initial manifestation of HIV\/AIDS. Case Rep Infect Dis 2019,2019,1-4","journal-title":"Case Rep Infect Dis"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2050313X20945562","DOI":"10.1177\/2050313X20945562","volume":"8","author":"Rezaie A","year":"2020","unstructured":"Rezaie A; Parmar R; Rendon C; Zell SC;  Hiv-Associated vacuolar myelopathy: A rare initial presentation of HIV SAGE Open Medical\tCase Reports 2020,8,2050313X20945562","journal-title":"Hiv-Associated vacuolar myelopathy: A rare initial presentation of HIV SAGE Open Medical\tCase Reports"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"Heaton R.K.","year":"2010","unstructured":"Heaton R.K.; Clifford D.B.; Franklin D.R.; HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010,75(23),2087-2096","journal-title":"Neurology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/acn3.227","volume":"2","author":"Grauer O.M.","year":"2015","unstructured":"Grauer O.M.; Reichelt D.; Gr\u00fcneberg U.; Neurocognitive decline in HIV patients is associated with ongoing T\u2010cell activation in the cerebrospinal fluid. Ann Clin Transl Neurol 2015,2(9),906-919","journal-title":"Ann Clin Transl Neurol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11011-014-9498-3","volume":"29","author":"Sacktor N.","year":"2014","unstructured":"Sacktor N.; Nakasujja N.; Redd A.D.; HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis 2014,29(2),261-268","journal-title":"Metab Brain Dis"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/2325957414553839","volume":"16","author":"Yusuf A.J.","year":"2017","unstructured":"Yusuf A.J.; Hassan A.; Mamman A.I.; Muktar H.M.; Suleiman A.M.; Baiyewu O.; Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. J Int Assoc Provid AIDS Care 2017,16(1),48-55","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/QAI.0000000000000273","volume":"67","author":"McDonnell J.","year":"1999","unstructured":"McDonnell J.; Haddow L.; Daskalopoulou M.; Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Deficien  Syndr 1999,67(2),120","journal-title":"J Acquir Immune Deficien  Syndr"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","volume":"95","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Liu M.; Lu Q.; Global prevalence and burden of HIV-associated neurocognitive disorder. Neurology 2020,95(19),e2610-e2621","journal-title":"Neurology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/0028-3886.121912","volume":"61","author":"Sharma H.","year":"2013","unstructured":"Sharma H.; Dubey T.N.; Raghuvanshi S.S.; Saxena R.; HIV neuropathy in pre-HAART patients and it\u2032s correlation with risk factors in Central India. Neurol India 2013,61(5),478-480","journal-title":"Neurol India"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4065\/81.2.213","volume":"81","author":"Ferrari S.","year":"2006","unstructured":"Ferrari S.; Vento S.; Monaco S.; Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc 2006,81(2),213-219","journal-title":"Mayo Clin Proc"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"657794","DOI":"10.3389\/fnagi.2021.657794","volume":"13","author":"Hou Y.C.","year":"2021","unstructured":"Hou Y.C.; Huang C.L.; Lu C.L.; The role of plasma neurofilament light protein for assessing cognitive impairment in patients with end-stage renal disease. Front Aging Neurosci 2021,13,657794","journal-title":"Front Aging Neurosci"},{"key":"ref=105","year":"2021","unstructured":"John Hopkins Medicine. Neurology and Neurosurgery Available from:  (Accessed on: August 2021).2021","journal-title":"Neurology and Neurosurgery"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"16020","DOI":"10.1038\/scsandc.2016.20","volume":"2","author":"Ernst F.","year":"2016","unstructured":"Ernst F.; Klausner F.; Kleindienst W.; Bartsch H.; Taylor N.; Trinka E.; Diagnostic challenges in vacuolar myelopathy: A didactic case report. Spinal Cord Ser Cases 2016,2(1),16020","journal-title":"Spinal Cord Ser Cases"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","volume":"271","author":"Cortright D.N.","year":"2004","unstructured":"Cortright D.N.; Szallasi A.; Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 2004,271(10),1814-1819","journal-title":"Eur J Biochem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"Attal N.","year":"2010","unstructured":"Attal N.; Cruccu G.; Baron R.; EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010,17(9),1113-e88","journal-title":"Eur J Neurol"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.280.18.1590","volume":"280","author":"Shlay J.C.","year":"1998","unstructured":"Shlay J.C.; Chaloner K.; Max M.B.; Acupuncture and amitriptyline for paindue to HIV-related peripheral neuropathy: A randomized controlled trial. JAMA 1998,280,1590-1595","journal-title":"JAMA"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","volume":"51","author":"Kieburtz K.","year":"1998","unstructured":"Kieburtz K.; Simpson D.; Yiannoutsos C.; A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998,51(6),1682-1688","journal-title":"Neurology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","volume":"60","author":"Simpson D.M.","year":"2003","unstructured":"Simpson D.M.; McArthur J.C.; Olney R.; Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial. Neurology 2003,60(9),1508-1514","journal-title":"Neurology"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1212\/WNL.54.11.2115","volume":"54","author":"Simpson D.M.","year":"2000","unstructured":"Simpson D.M.; Olney R.; McArthur J.C.; Khan A.; Godbold J.; Ebel-Frommer K.; A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000,54(11),2115-2119","journal-title":"Neurology"},{"key":"ref=113","unstructured":"Centers for Disease Control and Prevntions (CDC). Cytomegalovirus\tLaboratory Testinghttps Available from:"},{"key":"ref=114","first-page":"172","volume":"3","author":"Carlson A.","year":"2010","unstructured":"Carlson A.; Norwitz E.R.; Stiller R.J.; Cytomegalovirus infection in pregnancy: Should all women be screened? Rev Obstet Gynecol 2010,3(4),172-179","journal-title":"Rev Obstet Gynecol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"e0160493","DOI":"10.1371\/journal.pone.0160493","volume":"11","author":"Tsai H.P.","year":"2016","unstructured":"Tsai H.P.; Tsai Y.Y.; Lin I.T.; Comparison of two commercial automated nucleic acid extraction and integrated quantitation real-time PCR platforms for the detection of cytomegalovirus in plasma. PLoS One 2016,11(8),e0160493","journal-title":"PLoS One"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8067648","volume":"2019","author":"Newcomb G.","year":"2019","unstructured":"Newcomb G.; Mariuz P.; Lachant D.; CMV Encephalitis\/Radiculitis: The difficulty in diagnosing in an intubated patient. Case Rep Crit Care 2019,2019,1-4","journal-title":"Case Rep Crit Care"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12879-019-4643-6","volume":"19","author":"Perello R.","year":"2019","unstructured":"Perello R.; Vergara A.; Monclus E.; Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy. BMC Infect Dis 2019,19(1),1030","journal-title":"BMC Infect Dis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/00042560-199604150-00006","volume":"11","author":"Shepp D.H.","year":"1996","unstructured":"Shepp D.H.; Moses J.E.; Kaplan M.H.; Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival. J Acquir Immune Defic Syndr Hum Retrovirol 1996,11(5),460-468","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"e00964","DOI":"10.1128\/JCM.00964-21","volume":"59","author":"Miller H.","year":"2021","unstructured":"Miller H.; Simpson P.; Forman M.; A novel multiplexed enzyme-linked immunosorbent assay for the detection of IgG seroreactivity to cytomegalovirus (CMV) UL144. J Clin Microbiol 2021,59(8),e00964-e21","journal-title":"J Clin Microbiol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4103\/neuroindia.NI_535_16","volume":"65","author":"Suri V.","year":"2017","unstructured":"Suri V.; Nambirajan A.; Kataria V.; Sharma M.; Goyal V.; Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine. Neurol India 2017,65(5),1061-1064","journal-title":"Neurol India"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"Cortese I.","year":"2021","unstructured":"Cortese I.; Reich D.S.; Nath A.; Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 2021,17(1),37-51","journal-title":"Nat Rev Neurol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1148\/rg.287085135","volume":"28","author":"Smith A.B.","year":"2008","unstructured":"Smith A.B.; Smirniotopoulos J.G.; Rushing E.J.; From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008,28(7),2033-2058","journal-title":"Radiographics"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1086\/344280","volume":"186","author":"Sabath B.F.","year":"2002","unstructured":"Sabath B.F.; Major E.O.; Traffic of JC virus from sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy. J Infect Dis 2002,186(Suppl. 2),S180-S186","journal-title":"J Infect Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1089\/dna.2004.23.858","volume":"23","author":"Daniel D.C.","year":"2004","unstructured":"Daniel D.C.; Kinoshita Y.; Khan M.A.; Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol 2004,23(12),858-867","journal-title":"DNA Cell Biol"},{"key":"ref=125","first-page":"72","volume":"138","author":"Sharma S.K.","year":"2013","unstructured":"Sharma S.K.; Soneja M.; Ranjan S.; Progressive multifocal leucoencephalopathy in HIV\/AIDS: Observational study from a tertiary care centre in northern India. Indian J Med Res 2013,138(1),72-77","journal-title":"Indian J Med Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/WNL.0000000000003740","volume":"88","author":"Landi D.","year":"2017","unstructured":"Landi D.; De Rossi N.; Zagaglia S.; No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. Neurology 2017,88(12),1144-1152","journal-title":"Neurology"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","volume":"379","author":"Muftuoglu M.","year":"2018","unstructured":"Muftuoglu M.; Olson A.; Marin D.; Allogeneic BK virus\u2013specific T cells for progressive multifocal leukoencephalopathy. N Engl J Med 2018,379(15),1443-1451","journal-title":"N Engl J Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3748\/wjg.v21.i8.2269","volume":"21","author":"Adinolfi L.E.","year":"2015","unstructured":"Adinolfi L.E.; Nevola R.; Lus G.; Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World J Gastroenterol 2015,21(8),2269-2280","journal-title":"World J Gastroenterol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jare.2016.09.005","volume":"8","author":"Yarlott L.","year":"2017","unstructured":"Yarlott L.; Heald E.; Forton D.; Hepatitis C virus infection, and neurological and psychiatric disorders-a review. J Adv Res 2017,8(2),139-148","journal-title":"J Adv Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1212\/01.WNL.0000115177.74976.6C","volume":"62","author":"Ryan E.L.","year":"2004","unstructured":"Ryan E.L.; Morgello S.; Isaacs K.; Naseer M.; Gerits P.; Manhattan HIV Brain Bank. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004,62(6),957-962","journal-title":"Neurology"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fmed.2018.00366","volume":"5","author":"Ejeta E.","year":"2019","unstructured":"Ejeta E.; Dabsu R.; Prevalence of hepatitis C virus and HIV infection among pregnant women attending antenatal care clinic in western Ethiopia. Front Med 2019,5,366","journal-title":"Front Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4254\/wjh.v8.i12.545","volume":"8","author":"Mathew S.","year":"2016","unstructured":"Mathew S.; Faheem M.; Ibrahim S.M.; Hepatitis C virus and neurological damage. World J Hepatol 2016,8(12),545-556","journal-title":"World J Hepatol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"Platt L.","year":"2016","unstructured":"Platt L.; Easterbrook P.; Gower E.; Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. Lancet Infect Dis 2016,16(7),797-808","journal-title":"Lancet Infect Dis"},{"key":"ref=134","year":"2020","unstructured":"World Health Organization Herpes Simples Virus Available from: (Accessed on 01 August 2021).2020","journal-title":"Herpes Simples Virus"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/sti.76.4.282","volume":"76","author":"Miller R.F.","year":"2000","unstructured":"Miller R.F.; Howard M.R.; Frith P.; Perrons C.J.; Pecorella I.; Lucas S.B.; Herpesvirus infection of eye and brain in HIV infected patients. Sex Transm Infect 2000,76(4),282-286","journal-title":"Sex Transm Infect"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/archneur.65.5.596","volume":"65","author":"Berger J.R.","year":"2008","unstructured":"Berger J.R.; Houff S.; Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008,65(5),596-600","journal-title":"Arch Neurol"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/505496","volume":"43","author":"Strick L.B.","year":"2006","unstructured":"Strick L.B.; Wald A.; Celum C.; Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 2006,43(3),347-356","journal-title":"Clin Infect Dis"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1756285612456234","volume":"5","author":"Meyding-Lamad\u00e9 U.","year":"2012","unstructured":"Meyding-Lamad\u00e9 U.; Strank C.; Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord 2012,5(5),279-296","journal-title":"Ther Adv Neurol Disord"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.semdp.2017.04.003","volume":"34","author":"Linke-Serins\u00f6z E.","year":"2017","unstructured":"Linke-Serins\u00f6z E.; Fend F.; Quintanilla-Martinez L.; Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. In Seminars in diagnostic pathology 2017,34(4),352-363","journal-title":"In Seminars in diagnostic pathology"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-444-63849-6.00014-1","volume":"152","author":"Brandsma D.","year":"2018","unstructured":"Brandsma D.; Bromberg J.E.C.; Primary CNS lymphoma in HIV infection. Handb Clin Neurol 2018,152,177-186","journal-title":"Handb Clin Neurol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jnci\/djt158","volume":"105","author":"Gopal S.","year":"2013","unstructured":"Gopal S.; Patel M.R.; Yanik E.L.; Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst 2013,105(16),1221-1229","journal-title":"J Natl Cancer Inst"},{"key":"ref=142","first-page":"e472","volume":"4","author":"Chirico C.","year":"2018","unstructured":"Chirico C.; Izzo I.; Casari S.; Cattaneo C.; Doglietto F.; Castelli F.; AIDS-associated central nervous system lymphoma: the great mime. A case report and literature review. IDTM 2018,4(2),e472","journal-title":"IDTM"},{"key":"ref=143","first-page":"1178122X17731772","volume":"8","author":"Esau D.","year":"2017","unstructured":"Esau D.;  Viral causes of lymphoma: The history of Epstein-Barr\tvirus and human T-lymphotropic virus 1. Virology  2017,8,1178122X17731772"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/COH.0000000000000333","volume":"12","author":"Carbone A.","year":"2017","unstructured":"Carbone A.; Volpi C.C.; Gualeni A.V.; Gloghini A.; Epstein\u2013Barr virus associated lymphomas in people with HIV. Curr Opin HIV AIDS 2017,12(1),39-46","journal-title":"Curr Opin HIV AIDS"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"Shindiapina P.","year":"2020","unstructured":"Shindiapina P.; Ahmed E.H.; Mozhenkova A.; Abebe T.; Baiocchi R.A.; Immunology of EBV-related lymphoproliferative disease in HIV-positive individuals. Front Oncol 2020,10,1723","journal-title":"Front Oncol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1590\/S1807-59322011001200028","volume":"66","author":"dos Reis H.L.B.","year":"2011","unstructured":"dos Reis H.L.B.; Cavalcante F.S.; dos Santos K.R.N.; Passos M.R.L.; Ferreira D.C.; Herpes Zoster as a Sign of AIDS and nonadherence to antiretroviral therapy: A case report. Clinics 2011,66(12),2179-2181","journal-title":"Clinics"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1743-422X-7-147","volume":"7","author":"Chakraborty N.","year":"2010","unstructured":"Chakraborty N.; Bhattacharyya S.; De C.; Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virol J 2010,7(1),147","journal-title":"Virol J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1007\/s00415-020-10265-z","volume":"268","author":"Kennedy P.G.E.","year":"2021","unstructured":"Kennedy P.G.E.; An overview of viral infections of the nervous system in the immunosuppressed. J Neurol 2021,268(8),3026-3030","journal-title":"J Neurol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"Thwaites G.E.","year":"2004","unstructured":"Thwaites G.E.; Bang N.D.; Dung N.H.; Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004,351(17),1741-1751","journal-title":"N Engl J Med"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11904-009-0019-7","volume":"6","author":"Vinnard C.","year":"2009","unstructured":"Vinnard C.; Macgregor R.R.; Tuberculous meningitis in HIV-infected individuals. Curr HIV\/AIDS Rep 2009,6(3),139-145","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0022-510X(00)00440-8","volume":"181","author":"Katrak S.M.","year":"2000","unstructured":"Katrak S.M.; Shembalkar P.K.; Bijwe S.R.; Bhandarkar L.D.; The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000,181(1-2),118-126","journal-title":"J Neurol Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.20011614","volume":"195","author":"Hoshino Y.","year":"2002","unstructured":"Hoshino Y.; Nakata K.; Hoshino S.; Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002,195(4),495-505","journal-title":"J Exp Med"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1128\/JCM.01128-11","volume":"49","author":"Patel V.B.","year":"2011","unstructured":"Patel V.B.; Singh R.; Connolly C.; Kasprowicz V.; Ndung\u2019u T.; Dheda K.; Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis. J Clin Microbiol 2011,49(11),3971-3976","journal-title":"J Clin Microbiol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2010.07.029","volume":"483","author":"Misra U.K.","year":"2010","unstructured":"Misra U.K.; Kalita J.; Srivastava R.; Nair P.P.; Mishra M.K.; Basu A.; A study of cytokines in tuberculous meningitis: Clinical and MRI correlation. Neurosci Lett 2010,483(1),6-10","journal-title":"Neurosci Lett"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2008.02.060","volume":"436","author":"Nagesh Babu G.","year":"2008","unstructured":"Nagesh Babu G.; Kumar A.; Kalita J.; Misra U.K.; Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neurosci Lett 2008,436(1),48-51","journal-title":"Neurosci Lett"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-6405-10-16","volume":"10","author":"Luma H.N.","year":"2013","unstructured":"Luma H.N.; Tchaleu B.C.N.; Ngahane B.H.M.; Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: A cross sectional study. AIDS Res Ther 2013,10(1),16","journal-title":"AIDS Res Ther"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/373601","volume":"2013","author":"Efsen A.M.W.","year":"2013","unstructured":"Efsen A.M.W.; Panteleev A.M.; Grint D.; TB meningitis in HIV-positive patients in Europe and Argentina: Clinical outcome and factors associated with mortality. BioMed Res Int 2013,2013,1-9","journal-title":"BioMed Res Int"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/practneurol-2017-001754","volume":"18","author":"Hobbs E.","year":"2018","unstructured":"Hobbs E.; Vera J.H.; Marks M.; Barritt A.W.; Ridha B.H.; Lawrence D.; Neurosyphilis in patients with HIV. Pract Neurol 2018,18(3),211-218","journal-title":"Pract Neurol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1111\/j.1755-5949.2010.00183.x","volume":"16","author":"Ghanem K.G.","year":"2010","unstructured":"Ghanem K.G.; REVIEW: Neurosyphilis: A historical perspective and review. CNS Neurosci Ther 2010,16(5),e157-e168","journal-title":"CNS Neurosci Ther"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/hiv.12677","volume":"20","author":"Rotman L.","year":"2019","unstructured":"Rotman L.; Luo X.; Thompson A.; Mackesy-Amiti M.E.; Young L.R.; Young J.D.; Risk of neurosyphilis in HIV-infected persons with syphilis lacking signs or symptoms of central nervous system infection. HIV Med 2019,20(1),27-32","journal-title":"HIV Med"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1071\/SH14195","volume":"12","author":"Ho E.L.","year":"2015","unstructured":"Ho E.L.; Spudich S.S.; Neurosyphilis and the impact of HIV infection. Sex Health 2015,12(2),148-154","journal-title":"Sex Health"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.olq.0000162359.75509.9c","volume":"32","author":"Chesson H.W.","year":"2005","unstructured":"Chesson H.W.; Heffelfinger J.D.; Voigt R.F.; Collins D.; Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis 2005,32(5),265-269","journal-title":"Sex Transm Dis"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/OLQ.0b013e3181644b5e","volume":"35","author":"Taylor M.M.","year":"2008","unstructured":"Taylor M.M.; Aynalem G.; Olea L.M.; He P.; Smith L.V.; Kerndt P.R.; A consequence of the syphilis epidemic among men who have sex with men (MSM): Neurosyphilis in Los Angeles, 2001-2004. Sex Transm Dis 2008,35(5),430-434","journal-title":"Sex Transm Dis"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/s12879-019-4582-2","volume":"19","author":"Lu Y.","year":"2019","unstructured":"Lu Y.; Ke W.; Yang L.; Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: A case-control study. BMC Infect Dis 2019,19(1),1017","journal-title":"BMC Infect Dis"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","volume":"35","author":"Janier M.","year":"2021","unstructured":"Janier M.; Unemo M.; Dupin N.; Tiplica G.S.; Poto\u010dnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2021,35(3),574-588","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"Maziarz E.K.","year":"2016","unstructured":"Maziarz E.K.; Perfect J.R.; Cryptococcosis. Infect Dis Clin North Am 2016,30(1),179-206","journal-title":"Infect Dis Clin North Am"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1258\/ijsa.2010.010182","volume":"21","author":"Warkentien T.","year":"2010","unstructured":"Warkentien T.; Crum-Cianflone N.F.; An update on Cryptococcus among HIV-infected patients. Int J STD AIDS 2010,21(10),679-684","journal-title":"Int J STD AIDS"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12879-020-05129-w","volume":"20","author":"Derbie A.","year":"2020","unstructured":"Derbie A.; Mekonnen D.; Woldeamanuel Y.; Abebe T.; Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: A systematic review. BMC Infect Dis 2020,20(1),407","journal-title":"BMC Infect Dis"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S1473-3099(20)30771-4","volume":"21","author":"Stott K.E.","year":"2021","unstructured":"Stott K.E.; Loyse A.; Jarvis J.N.; Cryptococcal meningoencephalitis: Time for action. Lancet Infect Dis 2021,21(9),e259-e271","journal-title":"Lancet Infect Dis"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"Rajasingham R.","year":"2017","unstructured":"Rajasingham R.; Smith R.M.; Park B.J.; Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect Dis 2017,17(8),873-881","journal-title":"Lancet Infect Dis"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/infdis\/jiy602","volume":"219","author":"Tugume L.","year":"2019","unstructured":"Tugume L.; Rhein J.; Hullsiek K.H.; HIV-associated cryptococcal meningitis occurring at relatively higher CD4 counts. J Infect Dis 2019,219(6),877-883","journal-title":"J Infect Dis"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"e170554","DOI":"10.1590\/0074-02760170554","volume":"113","author":"Firacative C.","year":"2018","unstructured":"Firacative C.; Lizarazo J.; Illnait-Zaragoz\u00ed M.T.; Casta\u00f1eda E.; The status of cryptococcosis in Latin America. Mem Inst Oswaldo Cruz 2018,113(7),e170554","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix1143","volume":"66","author":"Ford N.","year":"2018","unstructured":"Ford N.; Shubber Z.; Jarvis J.N.; CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: A systematic review and meta-analysis. Clin Infect Dis 2018,66(Suppl. 2),S152-S159","journal-title":"Clin Infect Dis"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s40475-015-0046-y","volume":"2","author":"Abassi M.","year":"2015","unstructured":"Abassi M.; Boulware D.R.; Rhein J.; Cryptococcal meningitis: diagnosis and management update. Curr Trop Med Rep 2015,2(2),90-99","journal-title":"Curr Trop Med Rep"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/imr.12063","volume":"254","author":"Chang C.C.","year":"2013","unstructured":"Chang C.C.; Crane M.; Zhou J.; HIV and co-infections. Immunol Rev 2013,254(1),114-142","journal-title":"Immunol Rev"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"e01101","DOI":"10.1128\/mBio.01101-14","volume":"5","author":"Vu K.","year":"2014","unstructured":"Vu K.; Tham R.; Uhrig J.P.; Invasion of the central nervous system by cryptococcus neoformans requires a secreted fungal metalloprotease. MBio 2014,5(3),e01101-e01114","journal-title":"MBio"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/EC.00103-15","volume":"14","author":"Almeida F.","year":"2015","unstructured":"Almeida F.; Wolf J.M.; Casadevall A.; Virulence-associated enzymes of cryptococcus neoformans. Eukaryot Cell 2015,14(12),1173-1185","journal-title":"Eukaryot Cell"},{"key":"ref=178","first-page":"35","volume":"10","author":"Schop J.","year":"2007","unstructured":"Schop J.; Protective immunity against Cryptococcus neoformans infection. McGill J Med 2007,10(1),35-43","journal-title":"McGill J Med"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/infdis\/jit099","volume":"207","author":"Jarvis J.N.","year":"2013","unstructured":"Jarvis J.N.; Casazza J.P.; Stone H.H.; The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis 2013,207(12),1817-1828","journal-title":"J Infect Dis"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.4049\/jimmunol.176.11.7087","volume":"176","author":"Medoff B.D.","year":"2006","unstructured":"Medoff B.D.; Wain J.C.; Seung E.; CXCR3 and its ligands in a murine model of obliterative bronchiolitis: Regulation and function. J Immunol 2006,176(11),7087-7095","journal-title":"J Immunol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/00365549950163626","volume":"31","author":"Baril L.","year":"1999","unstructured":"Baril L.; Ancelle T.; Goulet V.; Thulliez P.; Tirard-Fleury V.; Carme B.; Risk factors for Toxoplasma infection in pregnancy: A case-control study in France. Scand J Infect Dis 1999,31(3),305-309","journal-title":"Scand J Infect Dis"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/2229-5070.190817","volume":"6","author":"Basavaraju A.","year":"2016","unstructured":"Basavaraju A.; Toxoplasmosis in HIV infection: An overview. Trop Parasitol 2016,6(2),129-135","journal-title":"Trop Parasitol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1086\/338003","volume":"185","author":"Subauste C.S.","year":"2002","unstructured":"Subauste C.S.; CD154 and type-1 cytokine response: From hyper IgM syndrome to human immunodeficiency virus infection. J Infect Dis 2002,185(Suppl. 1),S83-S89","journal-title":"J Infect Dis"},{"key":"ref=184","first-page":"1455","author":"Cohen O.","year":"1999","unstructured":"Cohen O.; Weissmal D.; Fauci K.S.;  The immune pathogenesis of HIV infection Fundamental Immunology 1999,1455-1509","journal-title":"The immune pathogenesis of HIV infection Fundamental Immunology"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","volume":"4","author":"Wang Z.D.","year":"2017","unstructured":"Wang Z.D.; Wang S.C.; Liu H.H.; Prevalence and burden of toxoplasma gondii infection in HIV-infected people: A systematic review and meta-analysis. Lancet HIV 2017,4(4),e177-e188","journal-title":"Lancet HIV"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1128\/JCM.43.10.5044-5047.2005","volume":"43","author":"Colombo F.A.","year":"2005","unstructured":"Colombo F.A.; Vidal J.E.; Oliveira A.C.P.; Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: Importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol 2005,43(10),5044-5047","journal-title":"J Clin Microbiol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","volume":"17","author":"Ben-Harari R.R.","year":"2017","unstructured":"Ben-Harari R.R.; Goodwin E.; Casoy J.; Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review. Drugs R D 2017,17(4),523-544","journal-title":"Drugs R D"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527322666230330083708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215162\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527322666230330083708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T07:18:41Z","timestamp":1703229521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215162\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527322666230330083708","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}